<?xml version="1.0" encoding="UTF-8"?>
<p>Alzheimer’s disease is characterized by the loss of cholinergic neurons, leading to the progressive reduction of acetylcholine in the brain and cognitive impairment. Inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) has great potential in the treatment of Alzheimer’s disease and special focus has been directed to these targets.</p>
